News

Public · Published

Microsoft Stock Suddenly Has an Anthropic Problem

Microsoft shares fell nearly 3% Tuesday after Anthropic introduced Claude Sheets and Claude Whiteboards in beta and made Claude Dashboards more widely available. These workplace tools expand Anthropic's business applications and could compete with Microsoft Office products, including Excel, as well as Google Sheets.

Published:

Updated:

What happened

Microsoft shares fell nearly 3% Tuesday after Anthropic introduced Claude Sheets and Claude Whiteboards in beta and made Claude Dashboards more widely available. These workplace tools expand Anthropic’s business applications and could compete with Microsoft Office products, including Excel, as well as Google Sheets.

Confirmed

Global impact / market context

If businesses adopt these tools instead of traditional office applications, Microsoft could face pressure on subscriptions that provide recurring revenue. That matters because Microsoft’s commercial and consumer products and cloud services revenue grew 16% in its latest fiscal year; weaker demand could slow future growth.

Analyst inference

Microsoft has already added Copilot to its productivity software, while Anthropic is expanding from conversational AI into spreadsheets, team planning, dashboards, and meeting support. The competition could make office software providers spend more on product development or risk losing customers and subscription revenue.

Analyst inference

What to watch

  1. Watch whether Claude Sheets and Whiteboards move beyond beta and gain business users; broader adoption would indicate whether Anthropic can compete for everyday office work. Analyst inference
  2. Track Microsoft’s next reported revenue growth for commercial and consumer products and cloud services, which could show whether its subscription base is holding up. Analyst inference
  3. Look for details on Claude Meetings, which Anthropic has previewed as an assistant for video calls and follow-up tasks; availability could broaden its workplace offering. Confirmed

Evidence